Thiochrome Enhances Acetylcholine Affinity at Muscarinic M4 Receptors: Receptor Subtype Selectivity via Cooperativity Rather than Affinity
- 1 January 2004
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 65 (1) , 257-266
- https://doi.org/10.1124/mol.65.1.257
Abstract
Thiochrome (2,7-dimethyl-5H-thiachromine-8-ethanol), an oxidation product and metabolite of thiamine, has little effect on the equilibrium binding of l-[3H]N-methyl scopolamine ([3H]NMS) to the five human muscarinic receptor subtypes (M1–M5) at concentrations up to 0.3 mM. In contrast, it inhibits [3H]NMS dissociation from M1 to M4 receptors at submillimolar concentrations and from M5 receptors at 1 mM. These results suggest that thiochrome binds allosterically to muscarinic receptors and has approximately neutral cooperativity with [3H]NMS at M1 to M4 and possibly M5 receptors. Thiochrome increases the affinity of acetylcholine (ACh) 3- to 5-fold for inhibiting [3H]NMS binding to M4 receptors but has no effect on ACh affinity at M1 to M3 or M5 receptors. Thiochrome (0.1 mM) also increases the direct binding of [3H]ACh to M4 receptors but decreases it slightly at M2 receptors. In agreement with the binding data, thiochrome does not affect the potency of ACh for stimulating the binding of guanosine 5′-O-(3-[35S]thiotriphosphate) ([35S]GTPγS) to membranes containing M1 to M3 receptors, but it increases ACh potency 3.5-fold at M4 receptors. It also selectively reduces the release of [3H]ACh from potassium-stimulated slices of rat striatum, which contain autoinhibitory presynaptic M4 receptors, but not from hippocampal slices, which contain presynaptic M2 receptors. We conclude that thiochrome is a selective M4 muscarinic receptor enhancer of ACh affinity and has neutral cooperativity with ACh at M1 to M3 receptors; it therefore demonstrates a powerful new form of selectivity, “absolute subtype selectivity”, which is derived from cooperativity rather than from affinity.Keywords
This publication has 21 references indexed in Scilit:
- Interactions of Orthosteric and Allosteric Ligands with [3H]Dimethyl-W84 at the Common Allosteric Site of Muscarinic M2 ReceptorsMolecular Pharmacology, 2003
- GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?Drug Discovery Today, 2003
- Allosteric binding sites on cell-surface receptors: novel targets for drug discoveryNature Reviews Drug Discovery, 2002
- Efficacy at g-protein-coupled receptorsNature Reviews Drug Discovery, 2002
- Calcium channels involved in the inhibition of acetylcholine release by presynaptic muscarinic receptors in rat striatumBritish Journal of Pharmacology, 1999
- The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonistsBritish Journal of Pharmacology, 1998
- Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptorsBiochemical Pharmacology, 1996
- Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng‐Prusoíf equationsBritish Journal of Pharmacology, 1993
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- THE RELEASE OF LABELLED ACETYLCHOLINE AND CHOLINE FROM CEREBRAL CORTICAL SLICES STIMULATED ELECTRICALLYBritish Journal of Pharmacology, 1974